Continuous cardiac monitoring detects brief, asymptomatic, heart rhythm abnormalities in one-third of older individuals and these symptoms are associated with an increased risk of stroke. 

The ARTESiA trial clearly demonstrates that use of the blood thinner apixaban reduces patient risk of stroke compared to treatment with aspirin, but is associated with an increased risk of bleeding. 

In this interview, Jeff S. Healey, MD, and Thomas F. Deering MD, FACC, discuss AHA Late-Breaker: Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation. 

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. In this interview, Kristin Newby, MD, FACC, and Nanette Kass Wenger MD, MACC, discuss Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

To improve our understanding of the basic principles in the treatment and management of patients with chronic heart disease, in this interview, Salim S. Virani, MD, PhD, FACC, and Roger S. Blumenthal, MD, FACC, discuss top takeaways from the ACC 2023 Guideline for Chronic CAD. 

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

Patients with worsening heart failure are at an extraordinarily high risk for mortality and readmission. Early identification and optimal management of these patients can significantly improve patient outcomes. Several clinical trials in these patients have shown benefit with various therapies. 

In this interview, Javed Butler, MD, MPH, MBA, FACC, and Matthew Martinez, MD, FACC, discuss Management of Worsening Heart Failure with Reduced Ejection Fraction. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

The SELECT trial extends findings from previous trials, which demonstrated cardiovascular benefit in diabetes mellitus (DM), to those without DM. In this interview, Abraham Lincoff, MD, FACC, and Glenn A. Hirsch MD, MHS, FACC, discuss AHA Late-Breaker: SELECT – Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

In this review, authors discuss how multimodality imaging can help to evaluate the left ventricular remodeling response and improve risk stratification in patients with moderate aortic stenosis.  

In this interview, Jeroen J Bax, MD, PhD, FACC, and Matt Cavender, MD, MPH, FACC, discuss JACC review, Managing Patients With Moderate Aortic Stenosis. 

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

In this interview, Andrew Kates, MD, FACC, and Alison L. Bailey, MD, FACC, discuss the top takeaways in general cardiology from 2023 including ARAMIS, ORBITA-2, and STOP-CA trials. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

While we know that statin treatment reduces the risk of stroke, heart attack and heart deaths in people at moderate-to-high risk, or with high cholesterol, in REPRIEVE statins decreased the risk in those at low-to-moderate risk, and with 'normal' cholesterol levels who would not usually be considered candidates for treatment. 

 In this interview, Pamela S. Douglas, MD, MACC, and Roger S. Blumenthal MD, FACC, discuss Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

In this interview, Dhanunjaya “DJ” Lakkireddy, MBBS, FACC, and Alison L. Bailey, MD, FACC discuss the top takeaways from 2023 in cardiac electrophysiology including AF and the latest guidelines and ARTESIA and MONITOR-AF studies.  

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

In this interview, Noel Bairey Merz, MD, FACC, and Alison L. Bailey, MD, FACC discuss the top takeaways from 2023 in Preventive Cardiology including the CLEAR-Outcomes, REPRIEVE, and SELECT trials.  

  Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL